South & Central America Influenza Vaccines Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Vaccine Type (Quadrivalent Vaccines and Trivalent Vaccines), Virus Type (Influenza Virus Type A and Influenza Virus Type B), Technology (Egg-based and Cell-based), Route of Administration (Injection and Nasal Spray), and Target Group (Infants, Children, Adults, and Elderly People)

The South & Central America influenza vaccines market is expected to grow from US$ 497.54 million in 2022 to US$ 736.35 million by 2028; it is estimated to grow at a CAGR of 6.8% from 2022 to 2028.

Increase in Government Support to Promote Influenza Vaccination

The governing bodies of various states and countries are supporting the promotion of vaccination through multiple activities and programs. By 2022, enough vaccines have been secured to cover all risk groups eligible for a government-funded flu vaccine through the NIP.

Below are a few more instances supporting the government support for influenza vaccination: In Oct 2021, with flu season approaching, the Provincial Government was encouraging all Newfoundlanders and Labradorians to get a flu shot in the year 2021. Starting October 25, 2021, the Regional Health Authorities (RHAs) have begun hosting free flu vaccination clinics. People can also get the vaccine through their family doctor or local pharmacy. Thus, increasing government support to promote influenza vaccination is driving the South & Central America influenza vaccines market.

Market Overview

The South & Central America influenza vaccines market is segmented into Brazil, Argentina, and the Rest of South & Central America. The market for influenza vaccines in the region is expected to experience growth opportunities during the forecast period. The influenza vaccines market in SAM is expected to grow owing to factors such as an increase in cases of influenza in the region, surge in various research activities in the region, rise in health awareness, and an increase in healthcare expenditure by the countries of the region.

South & Central America Influenza Vaccines Market Revenue and Forecast to 2028 (US$ Million)

Get more information on this report :

South & Central America Influenza Vaccines Market Segmentation

The South & Central America influenza vaccines market is segmented on the basis of vaccine type, virus type, technology, route of administration, target group, and country.

Based on vaccine type, the South & Central America influenza vaccines market is bifurcated into quadrivalent vaccines and trivalent vaccines. The quadrivalent vaccines segment registered a larger share of the market in 2022.

Based on virus type, the South & Central America influenza vaccines market is bifurcated into influenza virus type A and influenza virus type B. The influenza virus type A segment held a larger share of the market in 2022.

Based on technology, the South & Central America influenza vaccines market is divided into egg-based and cell-based. The egg-based segment held a larger share of the market in 2022.

Based on route of administration, the South & Central America influenza vaccines market is divided into injection and nasal spray. The injection segment held a larger share of the market in 2022.

Based on target group, the South & Central America influenza vaccines market is segmented into infants, children, adults, and elderly people. The infants segment held the largest share of the market in 2022.

Based on country, the South & Central America influenza vaccines market is segmented into Brazil, Argentina, and the Rest of South & Central America. Brazil dominated the market in 2022.

AstraZeneca; GlaxoSmithKline plc.; Mitsubishi Chemical Group Corporation; MYLAN N.V.; Sanofi; SEQIRUS; and Serum Institute of India Pvt. Ltd are the leading companies operating in the South & Central America influenza vaccines market.

1. Introduction

1.1 Study Scope

1.2 The Insight Partners Research Report Guidance

1.3 Market Segmentation

1.3.1 South & Central America Influenza Vaccines Market – By Vaccine Type

1.3.2 South & Central America Influenza Vaccines Market – By Virus Type

1.3.3 South & Central America Influenza Vaccines Market – By Technology

1.3.4 South & Central America Influenza Vaccines Market – By Route of Administration

1.3.5 South & Central America Influenza Vaccines Market – By Target Group

1.3.6 South & Central America Influenza Vaccines Market – By Country

2. South & Central America Influenza Vaccines Market – Key Takeaways

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. South & Central America Influenza Vaccines Market – Market Landscape

4.1 Overview

4.2 PEST Analysis

4.2.1 South and Central America PEST Analysis

4.3 Experts Opinion

5. South & Central America Influenza Vaccines Market – Key Market Dynamics

5.1 Market Drivers

5.1.1 Increase in Government Support to Promote Influenza Vaccination

5.1.2 Increasing Investment by Top Market Players and Governments

5.2 Market Restraints

5.2.1 High Cost of Vaccine Development

5.3 Market Opportunities

5.3.1 Emerging Economies

5.4 Future Trends

5.4.1 Strong Pipeline Candidates for Influenza Vaccines

5.5 Impact Analysis

6. Influenza Vaccine Market – South & Central America Analysis

6.1 South & Central America Influenza Vaccines Market, By Country - Forecasts And Analysis

6.2 South & Central America Influenza Vaccines Market Revenue Forecasts And Analysis

6.2.1 South & Central America : Influenza Vaccines Market, 2019–2028 (US$ Million)

7. South & Central America Influenza Vaccines Market Analysis and Forecasts To 2028 – By Vaccine Type

7.1 Overview

7.2 South & Central America Influenza Vaccines Market, By Vaccine Type 2022 & 2028 (%)

7.2.1 South and Central America: Influenza Vaccine Market, by Vaccine Type, 2019–2028 (USD Million)

7.3 Quadrivalent Vaccines

7.3.1 Overview

7.3.2 Quadrivalent Vaccines : South & Central America Influenza Vaccines Market Revenue and Forecast to 2028 (US$ Mn)

7.4 Trivalent Vaccines

7.4.1 Overview

7.4.2 Trivalent Vaccines : South & Central America Influenza Vaccines Market Revenue and Forecast to 2028 (US$ Mn)

8. South & Central America Influenza Vaccines Market Analysis and Forecasts To 2028 – By Virus Type

8.1 Overview

8.2 South & Central America Influenza Vaccines Market, By Virus Type 2022 & 2028 (%)

8.2.1 South and Central America: Influenza Vaccine Market, by Virus Type, 2019–2028 (USD Million)

8.3 Influenza Virus Type A

8.3.1 Overview

8.3.2 Influenza Virus Type A : Influenza Vaccines Market Revenue and Forecast to 2028 (US$ Mn)

8.4 Influenza Virus Type B

8.4.1 Overview

8.4.2 Influenza Virus Type B : Influenza Vaccines Market Revenue and Forecast to 2028 (US$ Mn)

9. South & Central America Influenza Vaccines Market Analysis and Forecasts To 2028 – By Technology

9.1 Overview

9.2 South & Central America Influenza Vaccines Market, By Technology 2022 & 2028 (%)

9.2.1 South and Central America: Influenza Vaccine Market, by Technology, 2019–2028 (USD Million)

9.3 Egg-based

9.3.1 Overview

9.3.2 Egg-based : South & Central America Influenza Vaccines Market Revenue and Forecast to 2028 (US$ Mn)

9.4 Cell-based

9.4.1 Overview

9.4.2 Cell-Based : South & Central America Influenza Vaccines Market Revenue and Forecast to 2028 (US$ Mn)

10. South & Central America Influenza Vaccines Market Analysis and Forecasts To 2028 – By Route of Administration

10.1 Overview

10.2 South & Central America Influenza Vaccines Market, By Route of Administration 2022 & 2028 (%)

10.3 Injection

10.3.1 Overview

10.3.2 Injection : South & Central America Influenza Vaccines Market Revenue and Forecast to 2028 (US$ Mn)

10.4 Nasal Spray

10.4.1 Overview

10.4.2 Nasal Spray: South & Central America Influenza Vaccines Market Revenue and Forecast to 2028 (US$ Mn)

11. South & Central America Influenza Vaccines Market Analysis and Forecasts To 2028 – By Target Group

11.1 Overview

11.2 South & Central America Influenza Vaccines Market, By Target Group 2022 & 2028 (%)

11.2.1 South and Central America: Influenza Vaccines Market, by Target Group, 2019–2028 (US$ Million)

11.3 Infants

11.3.1 Overview

11.3.2 Infants : South & Central America Influenza Vaccines Market Revenue and Forecast to 2028 (US$ Mn)

11.4 Children

11.4.1 Overview

11.4.2 Children: South & Central America Influenza Vaccines Market Revenue and Forecast to 2028 (US$ Mn)

11.5 Adults

11.5.1 Overview

11.5.2 Adults : South & Central America Influenza Vaccines Market Revenue and Forecast to 2028 (US$ Mn)

11.6 Elderly People

11.6.1 Overview

11.6.2 Elderly People: South & Central America Influenza Vaccines Market Revenue and Forecast to 2028 (US$ Mn)

12. South & Central America Influenza Vaccines Market Analysis and Forecasts To 2028 – Country Analysis

12.1 South and Central America Influenza Vaccine Market Revenue and Forecasts To 2028

12.1.1 Overview

12.1.3 South and Central America: Influenza Vaccine Market, by Country, 2022 & 2028 (%)

12.1.3.1 Brazil: Influenza Vaccine Market – Revenue and Forecast to 2028 (USD Million)

12.1.3.1.1 Overview

12.1.3.1.2 Brazil: Influenza Vaccine Market – Revenue and Forecast to 2028 (USD Million)

12.1.3.1.3 Brazil: Influenza Vaccine Market, by Vaccine Type, 2019–2028 (USD Million)

12.1.3.1.4 Brazil: Influenza Vaccine Market, by Virus Type, 2019–2028 (USD Million)

12.1.3.1.5 Brazil: Influenza Vaccine Market, by Technology, 2019–2028 (USD Million)

12.1.3.1.6 Brazil: Influenza Vaccine Market, by Route of Administration, 2019–2028 (USD Million)

12.1.3.1.7 Brazil: Influenza Vaccines Market, by Target Group, 2019–2028 (US$ Million)

12.1.3.2 Argentina: Influenza Vaccine Market – Revenue and Forecast to 2028 (USD Million)

12.1.3.2.1 Overview

12.1.3.2.2 Argentina: Influenza Vaccine Market – Revenue and Forecast to 2028 (USD Million)

12.1.3.2.3 Argentina: Influenza Vaccine Market, by Vaccine Type, 2019–2028 (USD Million)

12.1.3.2.4 Argentina: Influenza Vaccine Market, by Virus Type, 2019–2028 (USD Million)

12.1.3.2.5 Argentina: Influenza Vaccine Market, by Technology, 2019–2028 (USD Million)

12.1.3.2.6 Argentina: Influenza Vaccine Market, by Route of Administration, 2019–2028 (USD Million)

12.1.3.2.7 Argentina: Influenza Vaccines Market, by Target Group, 2019–2028 (US$ Million)

12.1.3.3 Rest of South and Central America: Influenza Vaccine Market – Revenue and Forecast to 2028 (USD Million)

12.1.3.3.1 Overview

12.1.3.3.2 Rest of South and Central America: Influenza Vaccine Market – Revenue and Forecast to 2028 (USD Million)

12.1.3.3.3 Rest of South and Central America: Influenza Vaccine Market, by Vaccine Type, 2019–2028 (USD Million)

12.1.3.3.4 Rest of South and Central America: Influenza Vaccine Market, by Virus Type, 2019–2028 (USD Million)

12.1.3.3.5 Rest of South and Central America: Influenza Vaccine Market, by Technology, 2019–2028 (USD Million)

12.1.3.3.6 Rest of South and Central America: Influenza Vaccine Market, by Route of Administration, 2019–2028 (USD Million)

12.1.3.3.7 Rest of South and Central America: Influenza Vaccines Market, by Target Group, 2019–2028 (US$ Million)

13. South & Central America Influenza Vaccine Market –Industry Landscape

13.1 Overview

13.2 Growth Strategies in the Influenza Vaccine Market, 2021-2028

13.3 Inorganic Growth Strategies

13.3.1 Overview

13.4 Organic Growth Strategies

13.4.1 Overview

14. Company Profiles

14.1 SEQIRUS

14.1.1 Key Facts

14.1.2 Business Description

14.1.3 Products and Services

14.1.4 Financial Overview

14.1.5 SWOT Analysis

14.1.6 Key Developments

14.2 Sanofi

14.2.1 Key Facts

14.2.2 Business Description

14.2.3 Products and Services

14.2.4 Financial Overview

14.2.5 SWOT Analysis

14.2.6 Key Developments

14.3 GlaxoSmithKline plc.

14.3.1 Key Facts

14.3.2 Business Description

14.3.3 Products and Services

14.3.4 Financial Overview

14.3.5 SWOT Analysis

14.3.6 Key Developments

14.4 Mitsubishi Chemical Group Corporation

14.4.1 Key Facts

14.4.2 Business Description

14.4.3 Products and Services

14.4.4 Financial Overview

14.4.5 SWOT Analysis

14.4.6 Key Developments

14.5 Serum Institute of India Pvt. Ltd

14.5.1 Key Facts

14.5.2 Business Description

14.5.3 Products and Services

14.5.4 Financial Overview

14.5.5 SWOT Analysis

14.5.6 Key Developments

14.6 MYLAN N.V.

14.6.1 Key Facts

14.6.2 Business Description

14.6.3 Products and Services

14.6.4 Financial Overview

14.6.5 SWOT Analysis

14.6.6 Key Developments

14.7 AstraZeneca

14.7.1 Key Facts

14.7.2 Business Description

14.7.3 Products and Services

14.7.4 Financial Overview

14.7.5 SWOT Analysis

14.7.6 Key Developments

15. Appendix

15.1 About The Insight Partners

15.2 Glossary of Terms

LIST OF TABLES

Table 1. Below are a few instances of companies and their pipeline products:

Table 2. South & Central America Influenza Vaccines Market– Revenue and Forecast to 2028 (US$ Million)

Table 3. South and Central America: Influenza Vaccine Market, by Vaccine Type – Revenue and Forecast to 2028 (USD Million)

Table 4. South and Central America: Influenza Vaccine Market, by Virus Type – Revenue and Forecast to 2028 (USD Million)

Table 5. South and Central America: Influenza Vaccine Market, by Technology – Revenue and Forecast to 2028 (USD Million)

Table 6. South and Central America Influenza Vaccines Market, by Target Group– Revenue and Forecast to 2028 (USD Million)

Table 7. Brazil: Influenza Vaccine Market, by Vaccine Type – Revenue and Forecast to 2028 (USD Million)

Table 8. Brazil: Influenza Vaccine Market, by Virus Type – Revenue and Forecast to 2028 (USD Million)

Table 9. Brazil: Influenza Vaccine Market, by Technology – Revenue and Forecast to 2028 (USD Million)

Table 10. Brazil: Influenza Vaccine Market, by Route of Administration– Revenue and Forecast to 2028 (USD Million)

Table 11. Brazil Influenza Vaccines Market, by Target Group– Revenue and Forecast to 2028 (USD Million)

Table 12. Argentina: Influenza Vaccine Market, by Vaccine Type – Revenue and Forecast to 2028 (USD Million)

Table 13. Argentina: Influenza Vaccine Market, by Virus Type – Revenue and Forecast to 2028 (USD Million)

Table 14. Argentina: Influenza Vaccine Market, by Technology – Revenue and Forecast to 2028 (USD Million)

Table 15. Argentina: Influenza Vaccine Market, by Route of Administration– Revenue and Forecast to 2028 (USD Million)

Table 16. Argentina Influenza Vaccines Market, by Target Group– Revenue and Forecast to 2028 (USD Million)

Table 17. Rest of South and Central America: Influenza Vaccine Market, by Vaccine Type – Revenue and Forecast to 2028 (USD Million)

Table 18. Rest of South and Central America: Influenza Vaccine Market, by Virus Type – Revenue and Forecast to 2028 (USD Million)

Table 19. Rest of South and Central America: Influenza Vaccine Market, by Technology – Revenue and Forecast to 2028 (USD Million)

Table 20. Rest of South and Central America: Influenza Vaccine Market, by Route of Administration– Revenue and Forecast to 2028 (USD Million)

Table 21. Rest of South and Central America Influenza Vaccines Market, by Target Group– Revenue and Forecast to 2028 (USD Million)

Table 22. Recent Inorganic Growth Strategies in the Influenza Vaccine Market

Table 23. Recent Organic Growth Strategies in the Influenza Vaccine Market

Table 24. Glossary of Terms, Influenza Vaccines Market

LIST OF FIGURES

Figure 1. South & Central America Influenza Vaccines Market Segmentation

Figure 2. South & Central America Influenza Vaccines Market Segmentation, by Country

Figure 3. South & Central America Influenza Vaccines Market Overview

Figure 4. Quadrivalent Vaccines Segment Held Largest Share of Product Segment in South & Central America Influenza Vaccines Market

Figure 5. Brazil Is Expected to Show Remarkable Growth During the Forecast Period

Figure 6. South and Central America: PEST Analysis

Figure 7. Experts Opinion

Figure 8. South & Central America Influenza Vaccines Market – Revenue Forecasts and Analysis – 2020- 2028

Figure 9. South & Central America Influenza Vaccines Market, by Vaccine Type 2022 & 2028 (%)

Figure 10. Quadrivalent Vaccines: South & Central America Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 11. Trivalent Vaccines: South & Central America Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 12. South & Central America Influenza Vaccines Market, by Virus Type 2022 & 2028 (%)

Figure 13. Influenza Virus Type A : Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 14. Influenza Virus Type B: Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 15. South & Central America Influenza Vaccines Market, by Technology 2022 & 2028 (%)

Figure 16. Egg-based: South & Central America Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 17. Cell-Based: South & Central America Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 18. South & Central America Influenza Vaccines Market, by Route of Administration 2022 & 2028 (%)

Figure 19. Injection: South & Central America Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 20. Nasal Spray: South & Central America Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 21. South & Central America Influenza Vaccines Market, by Target Group 2022 & 2028 (%)

Figure 22. Infants : South & Central America Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 23. Children: South & Central America Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 24. Adults: South & Central America Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 25. Elderly People: South & Central America Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 26. South and Central America: Influenza Vaccine Market, by Key Country – Revenue (2022) (USD Million)

Figure 27. South and Central America: Influenza Vaccine Market, by Country, 2022 & 2028 (%)

Figure 28. Brazil: Influenza Vaccine Market – Revenue and Forecast to 2028 (USD Million)

Figure 29. Argentina: Influenza Vaccine Market – Revenue and Forecast to 2028 (USD Million)

Figure 30. Rest of South and Central America: Influenza Vaccine Market – Revenue and Forecast to 2028 (USD Million)

Figure 31. Growth Strategies in the Influenza Vaccine Market, 2021-2028

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the South & Central America influenza vaccines market.

Highlights key business priorities in order to assist companies to realign their business strategies.

The key findings and recommendations highlight crucial progressive industry trends in South & Central America influenza vaccines market, thereby allowing players across the value chain to develop effective long-term strategies.

Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.

Scrutinize in-depth South & Central America market trends and outlook coupled with the factors driving the market, as well as those hindering it.

Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title
Company
Requirement
Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports

Report Name	Published Date
South America Wind Turbine Condition Monitoring Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Component (Hardware, and Software a..	May 2022
South and Central America Automotive System Simulation Software Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (Transmission,..	May 2022
South and Central America In-Office Teeth Whitening Products Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product (Double-Syring..	May 2022

Purchase Options

Single User License

$3000

$2400

Site License

$4000

$3200

Enterprise License

$5000